Ivan Jarry
CEO
ObvioHealth
ObvioHealth offers the ObvioGo® 2.0 platform, which utilizes digital tools for real-time data capture and participant engagement in clinical trials. This technology addresses inefficiencies in traditional trial management by providing customizable study designs and enhancing data accuracy, resulting in faster recruitment and improved compliance.
- Artificial Intelligence
- Data & Analytics
- Digital Health
- Healthcare Technology
- Software Only
Updated 6 months ago
Funding
Raised to date
$109.7MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Traditional clinical trials often suffer from inefficiencies in data capture, participant engagement, and overall management, leading to slower recruitment, reduced compliance, and compromised data accuracy. Existing tools lack the flexibility to adapt to diverse study designs and the ability to provide real-time insights.
Solution
ObvioHealth offers ObvioGo® 2.0, a digital platform designed to streamline and enhance clinical trials through advanced technology. The platform provides customizable study designs, allowing for efficient adaptation to specific research needs. By integrating electronic data capture (EDC) with custom workflow solutions, ObvioGo® 2.0 ensures seamless trial management and real-time compliance. The ObvioGo® app enhances participant engagement by consolidating all trial-related activities into a single, user-friendly interface, improving data accuracy and overall study outcomes.
Target Audience
The primary target audience includes pharmaceutical companies, clinical research organizations (CROs), and research institutions seeking to improve the efficiency, accuracy, and participant engagement in their clinical trials.
Features
- Customizable study designer enabling efficient creation and deployment of clinical trials
- Integrated electronic data capture (EDC) for streamlined data collection
- Real-time data capture and analytics for optimized study build and amendments
- ObvioGo® mobile app providing a frictionless participant interface with eConsent and ePRO capabilities
- Patient engagement suite to motivate and support participation throughout the trial
- Device integration for capturing vitals, signals, and symptoms to improve data quality
- Study Manager combining EDC with custom workflow solutions for seamless trial management